A-R: ADA patient needs periodic infusion of engineered lymphocytes
The same question, asked 2 times: 2023*, 2025. Every wording below, oldest first.
Try each one first, then open its answer.
Question 1
2023
Two statements are given, one labelled Assertion (A) and the other labelled Reason (R). Select the correct answer from the options given below.13Assertion (A) : A patient of ADA deficiency undergoing treatment for gene therapy requires periodic infusion of genetically engineered lymphocytes. Reason (R) : Lymphocytes are immortal.Tap an option to check your answer.
Question 2
2025
Two statements are given, one labelled Assertion (A) and the other labelled Reason (R). Select the correct answer from the options given below.16Assertion (A) : A patient of ADA-deficiency requires periodic or repeated infusion of genetically-engineered lymphocytes. Reason (R) : Lymphocytes are not immortal, but have life span.Tap an option to check your answer.